• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Antibody maintenance 3 months after complete messenger RNA COVID-19 vaccination in haemodialysis patients.

作者信息

Broseta José Jesús, Rodríguez-Espinosa Diana, Bedini José Luis, Rodríguez Néstor, Maduell Francisco

机构信息

Department of Nephrology and Renal Transplantation, Hospital Clínic of Barcelona, Barcelona, Spain.

Department of Biochemistry and Molecular Genetics, Hospital Clínic of Barcelona, Barcelona, Spain.

出版信息

Nephrol Dial Transplant. 2021 Dec 2;36(12):2340-2341. doi: 10.1093/ndt/gfab272.

DOI:10.1093/ndt/gfab272
PMID:34534347
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8500012/
Abstract
摘要

相似文献

1
Antibody maintenance 3 months after complete messenger RNA COVID-19 vaccination in haemodialysis patients.血液透析患者完成信使核糖核酸新冠疫苗接种3个月后的抗体维持情况。
Nephrol Dial Transplant. 2021 Dec 2;36(12):2340-2341. doi: 10.1093/ndt/gfab272.
2
Time-dependent evolution of IgG antibody levels after first and second dose of mRNA-based SARS-CoV-2 vaccination in haemodialysis patients: a multicentre study.血液透析患者接种 mRNA 基于 SARS-CoV-2 疫苗后第一剂和第二剂后 IgG 抗体水平的时间依赖性演变：一项多中心研究。
Nephrol Dial Transplant. 2022 Jan 25;37(2):375-381. doi: 10.1093/ndt/gfab293.
3
Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months.维持性透析患者接种 SARS-CoV-2 疫苗后 6 个月的血清学反应。
Clin J Am Soc Nephrol. 2022 Mar;17(3):403-413. doi: 10.2215/CJN.12250921. Epub 2022 Feb 10.
4
Neutralizing SARS-CoV-2 antibody response in dialysis patients after the first dose of the BNT162b2 mRNA COVID-19 vaccine: the war is far from being won.首次接种BNT162b2 mRNA新冠疫苗后透析患者体内中和新型冠状病毒2抗体的反应：这场战斗远未胜利。
Kidney Int. 2021 Jun;99(6):1494-1496. doi: 10.1016/j.kint.2021.04.010. Epub 2021 Apr 20.
5
Improved immunologic response to COVID-19 vaccine with prolonged dosing interval in haemodialysis patients.血液透析患者延长接种间隔可提高对 COVID-19 疫苗的免疫应答。
Scand J Immunol. 2022 May;95(5):e13152. doi: 10.1111/sji.13152. Epub 2022 Mar 7.
6
Humoral response after SARS-CoV-2 vaccination in patients undergoing maintenance haemodialysis: loss of immunity, third dose and non-responders.接受维持性血液透析的患者接种新型冠状病毒2疫苗后的体液免疫反应：免疫丧失、第三剂疫苗和无反应者
Nephrol Dial Transplant. 2022 Jan 25;37(2):390-392. doi: 10.1093/ndt/gfab299.
7
Waning humoral response 6 months after SARS-CoV-2 vaccination with the mRNA-BNT162b2 vaccine in hemodialysis patients: time for a boost.血液透析患者接种mRNA-BNT162b2疫苗6个月后体液免疫反应减弱：是时候加强接种了。
Kidney Int. 2021 Dec;100(6):1334-1335. doi: 10.1016/j.kint.2021.10.006. Epub 2021 Oct 14.
8
Humoral response to SARS-CoV-2 vaccination in haemodialysis patients and a matched cohort.血液透析患者与匹配队列对 SARS-CoV-2 疫苗的体液反应。
BMJ Open. 2022 Nov 8;12(11):e065741. doi: 10.1136/bmjopen-2022-065741.
9
SARS-CoV-2 mRNA vaccination is not associated with the induction of anti-HLA or non-HLA antibodies.SARS-CoV-2 mRNA 疫苗接种与抗 HLA 或非 HLA 抗体的诱导无关。
Transpl Immunol. 2022 Oct;74:101670. doi: 10.1016/j.trim.2022.101670. Epub 2022 Jul 11.
10
Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients.英国血液透析患者新冠病毒疫苗接种后的中和抗体
Lancet. 2021 Sep 18;398(10305):1038-1041. doi: 10.1016/S0140-6736(21)01854-7. Epub 2021 Aug 13.

引用本文的文献

1
Dynamics of SARS-CoV-2-Spike-reactive antibody and T-cell responses in chronic kidney disease patients within 3 months after COVID-19 full vaccination.新冠病毒病全程接种疫苗后3个月内慢性肾脏病患者中SARS-CoV-2刺突蛋白反应性抗体和T细胞反应的动态变化
Clin Kidney J. 2022 Apr 9;15(8):1562-1573. doi: 10.1093/ckj/sfac093. eCollection 2022 Aug.
2
Diminished Short- and Long-Term Antibody Response after SARS-CoV-2 Vaccination in Hemodialysis Patients.血液透析患者接种新型冠状病毒 2 型疫苗后短期和长期抗体反应减弱。
Vaccines (Basel). 2022 Apr 13;10(4):605. doi: 10.3390/vaccines10040605.
3
Humoral Response after Three Doses of mRNA-1273 or BNT162b2 SARS-CoV-2 Vaccines in Hemodialysis Patients.血液透析患者接种三剂mRNA-1273或BNT162b2新冠病毒疫苗后的体液免疫反应
Vaccines (Basel). 2022 Mar 27;10(4):522. doi: 10.3390/vaccines10040522.
4
Antibody maintenance and breakthrough infections 6 months after complete COVID-19 vaccination with the mRNA-1273 and BNT162b2 vaccines in hemodialysis patients.血液透析患者接种mRNA-1273和BNT162b2疫苗完成新冠病毒疫苗全程接种6个月后的抗体维持情况及突破性感染
Clin Kidney J. 2021 Dec 16;15(4):818-819. doi: 10.1093/ckj/sfab282. eCollection 2022 Apr.
5
Waning but persistent humoral response 6 months after the third dose of the mRNA BNT162b2 vaccine in hemodialysis and peritoneal dialysis patients.血液透析和腹膜透析患者在接种第三剂mRNA BNT162b2疫苗6个月后体液免疫反应减弱但持续存在。
J Nephrol. 2022 Apr;35(3):783-785. doi: 10.1007/s40620-022-01276-2. Epub 2022 Feb 22.
6
Incidence of severe breakthrough SARS-CoV-2 infections in vaccinated kidney transplant and haemodialysis patients.接种疫苗的肾移植和血液透析患者中严重突破性 SARS-CoV-2 感染的发生率。
J Nephrol. 2022 Apr;35(3):769-778. doi: 10.1007/s40620-022-01257-5. Epub 2022 Feb 21.
7
Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.维持性血液透析患者对mRNA BNT162b2疫苗抗体反应的纵向分析：6个月随访
Front Med (Lausanne). 2021 Dec 24;8:796676. doi: 10.3389/fmed.2021.796676. eCollection 2021.

本文引用的文献

1
Antibody titres decline 3-month post-vaccination with BNT162b2.接种 BNT162b2 疫苗 3 个月后，抗体滴度下降。
Emerg Microbes Infect. 2021 Dec;10(1):1495-1498. doi: 10.1080/22221751.2021.1953403.
2
SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.SARS-CoV-2 mRNA 疫苗可诱导持久的人体生发中心反应。
Nature. 2021 Aug;596(7870):109-113. doi: 10.1038/s41586-021-03738-2. Epub 2021 Jun 28.
3
Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients.血液透析患者接种 mRNA-1273 和 BNT162b2 新冠病毒疫苗的体液和细胞免疫反应。
Am J Kidney Dis. 2021 Oct;78(4):571-581. doi: 10.1053/j.ajkd.2021.06.002. Epub 2021 Jun 24.
4
Antibody Response to mRNA-1273 SARS-CoV-2 Vaccine in Hemodialysis Patients with and without Prior COVID-19.血液透析患者接种mRNA-1273新冠病毒疫苗后的抗体反应：有或无既往新冠病毒感染史的对比
Clin J Am Soc Nephrol. 2021 Aug;16(8):1258-1260. doi: 10.2215/CJN.04080321. Epub 2021 May 24.
5
Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers.西门子定量 SARS-CoV-2 刺突 IgG 检测试剂盒（sCOVG）的临床验证显示出了更高的灵敏度，与病毒中和滴度有良好的相关性。
Clin Chem Lab Med. 2021 Apr 9;59(8):1453-1462. doi: 10.1515/cclm-2021-0214. Print 2021 Jul 27.
6
Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis.接受维持性血液透析患者对辉瑞 BNT162b2 疫苗的体液反应。
Clin J Am Soc Nephrol. 2021 Jul;16(7):1037-1042. doi: 10.2215/CJN.03500321. Epub 2021 Apr 6.
7
Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19.新冠病毒mRNA-1273疫苗第二剂接种后6个月的抗体持久性
N Engl J Med. 2021 Jun 10;384(23):2259-2261. doi: 10.1056/NEJMc2103916. Epub 2021 Apr 6.
8
SARS-CoV-2 Infection in a Spanish Cohort of CKD-5D Patients: Prevalence, Clinical Presentation, Outcomes, and De-Isolation Results.西班牙 CKD-5D 患者队列中 SARS-CoV-2 感染：患病率、临床特征、结局和解除隔离结果。
Blood Purif. 2021;50(4-5):531-538. doi: 10.1159/000510557. Epub 2020 Dec 22.
9
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.SARS-CoV-2 mRNA-1273疫苗接种后反应的持久性。
N Engl J Med. 2021 Jan 7;384(1):80-82. doi: 10.1056/NEJMc2032195. Epub 2020 Dec 3.
10
Prevalence of COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening.采用血清学筛查检测血液透析患者中新冠病毒感染的患病率
J Am Soc Nephrol. 2020 Dec;31(12):2966-2967. doi: 10.1681/ASN.2020081193. Epub 2020 Sep 29.